The choice of using HSP90 is also related to the fact that HSP90 inhibitor has been shown to be highly effective against ALK+ lung cancer cells as well as ALK+ALCL cells in preclinical and clinical studies35, 36. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.